Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Buscombe

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Future Oncology (London, England)|May 10, 2016
Long-term efficacy of (90)Y-DOTATATE in patients with nonresectable pancreatic and small bowel neuroendocrine neoplasmsWojciech Rogowski, Ewa Wachuła, Anna Lewczuk, et al.
Nuclear Medicine Review. Central & Eastern Europe|January 11, 2018
The use of 67Ga scintigraphy in patients with sarcoidosisEwa Malinowska, Anna Doboszyńska, Anna Śliwińska, et al.
Nuclear Medicine Communications|April 20, 2004
Prediction of clinical outcome in treated neuroendocrine tumours of carcinoid type using functional volumes on 111In-pentetreotide SPECT imagingGnanasegaran Gopinath, Akhtar Ahmed, John R Buscombe, et al.
World Journal of Nuclear Medicine|May 3, 2018
First Results and Experience with PRRT in South AfricaMariza Vorster, M R Modiselle, C S Corbett, et al.
Nuclear Medicine Communications|April 19, 2020
COVID-19: guidance for infection prevention and control in nuclear medicineJohn R Buscombe, Alp Notghi, Jilly Croasdale, et al.
Journal of Imaging|June 27, 2023
Clinical Utility of <sup>18</sup>Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (<sup>18</sup>F-FDG PET/CT) in Multivisceral Transplant PatientsShao Jin Ong, Lisa M Sharkey, Kai En Low, et al.
Nature Reviews. Neurology|April 4, 2018
PET imaging of the neurovascular interface in cerebrovascular diseaseNicholas R Evans, Jason M Tarkin, John R Buscombe, et al.
Neuroendocrinology|April 8, 2006
Intertumoural variability in functional imaging within patients suffering from neuroendocrine tumours. An observational, cross-sectional studyAnn-Marie Quigley, John R Buscombe, Tahir Shah, et al.
Nature Reviews. Neurology|October 7, 2017
PET imaging of the neurovascular interface in cerebrovascular diseaseNicholas R Evans, Jason M Tarkin, John R Buscombe, et al.
Journal of Clinical Medicine|April 30, 2021
Radiological and Clinical Efficacy of Intra-Arterial <sup>90</sup>Y-DOTATATE in Patients with Unresectable, Progressive, Liver Dominant Neuroendocrine NeoplasmsAgnieszka Kolasińska-Ćwikła, Mirosław L Nowicki, Artur J Sankowski, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Future Oncology (London, England)|May 10, 2016
Long-term efficacy of (90)Y-DOTATATE in patients with nonresectable pancreatic and small bowel neuroendocrine neoplasmsWojciech Rogowski, Ewa Wachuła, Anna Lewczuk, et al.
Nuclear Medicine Review. Central & Eastern Europe|January 11, 2018
The use of 67Ga scintigraphy in patients with sarcoidosisEwa Malinowska, Anna Doboszyńska, Anna Śliwińska, et al.
Nuclear Medicine Communications|April 20, 2004
Prediction of clinical outcome in treated neuroendocrine tumours of carcinoid type using functional volumes on 111In-pentetreotide SPECT imagingGnanasegaran Gopinath, Akhtar Ahmed, John R Buscombe, et al.
World Journal of Nuclear Medicine|May 3, 2018
First Results and Experience with PRRT in South AfricaMariza Vorster, M R Modiselle, C S Corbett, et al.
Nuclear Medicine Communications|April 19, 2020
COVID-19: guidance for infection prevention and control in nuclear medicineJohn R Buscombe, Alp Notghi, Jilly Croasdale, et al.
Journal of Imaging|June 27, 2023
Clinical Utility of <sup>18</sup>Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (<sup>18</sup>F-FDG PET/CT) in Multivisceral Transplant PatientsShao Jin Ong, Lisa M Sharkey, Kai En Low, et al.
Nature Reviews. Neurology|April 4, 2018
PET imaging of the neurovascular interface in cerebrovascular diseaseNicholas R Evans, Jason M Tarkin, John R Buscombe, et al.
Neuroendocrinology|April 8, 2006
Intertumoural variability in functional imaging within patients suffering from neuroendocrine tumours. An observational, cross-sectional studyAnn-Marie Quigley, John R Buscombe, Tahir Shah, et al.
Nature Reviews. Neurology|October 7, 2017
PET imaging of the neurovascular interface in cerebrovascular diseaseNicholas R Evans, Jason M Tarkin, John R Buscombe, et al.
Journal of Clinical Medicine|April 30, 2021
Radiological and Clinical Efficacy of Intra-Arterial <sup>90</sup>Y-DOTATATE in Patients with Unresectable, Progressive, Liver Dominant Neuroendocrine NeoplasmsAgnieszka Kolasińska-Ćwikła, Mirosław L Nowicki, Artur J Sankowski, et al.
Pageof 5